PharmSol operates as a single window service provider right from development of process, to scale up and commercialization of products for all market segments – EU, US, WHO and other semi-regulated markets.
As part of development, PharmSol provides the complete solutions comprising of the following components.
- Product Development (API & FDF)
- Patent Evaluation
- Technology Transfer
- Scale up
- BE Studies
- Licensing In / Out
PharmSol is one of leading provider of EU GMP (QP Audits) and works very closely both with EU MA Holders as well manufacturers of APIs / KSMs. Considering the costs and hardships associated with both sides, PharmSol has launched two innovative models of GMP Audits, namely ‘Shared Audits’ which is designed for MA Holders and ‘Bulk Audits’ which is designed for manufacturers.